6533b824fe1ef96bd1280b6e
RESEARCH PRODUCT
In Reply – Association of Renin Angiotensin System Blockers with Outcomes in Patients With COVID-19
Carl J. LavieFabian Sanchis-gomarGiuseppe LippiBrandon Michael HenryCarme Perez-quilissubject
2019-20 coronavirus outbreakmedicine.medical_specialtyhypertensionCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Renin-Angiotensin COVID-19 hypertensionCOVID-19General MedicineRenin-Angiotensin SystemBetacoronavirusInternal medicineRenin–angiotensin systemHumansMedicineIn patientCoronavirus InfectionsbusinessPandemicsRenin-AngiotensinLetter to the Editoryear | journal | country | edition | language |
---|---|---|---|---|
2020-08-10 | Mayo Clinic Proceedings |